Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial.
暂无分享，去创建一个
J. Briones | M. Federico | M. Petrini | M. Notter | A. Chiappella | S. Luminari | D. Caballero | L. Kayitalire | M. Dyer | S. Bologna | A. Montanini | A. Barbato